- The EC has the contractual framework in place to purchase the initial 200M doses on behalf of all EU Member States once the vaccine has proven safe and effective. The agreement includes an option to purchase up to an additional 200M dose
- If approved, the EC expects to facilitate a process for the allocation of the vaccine doses among the member states.
- The exploratory talks concluded today are intended to result in an Advance Purchase Agreement to be financed with the Emergency Support Instrument, which has funds for vaccines with different profiles and produced by different companies
Click here to read full press release/ article | Ref: European Commission | Image: USA Today